Discover the most recent news about our Company.
Cardiovascular disease (CVD) claims the lives of over 4 million people in Europe every year. Dyslipidemia, a disorder characterized by
NMR metabolomics & AI in neonatal health Did you know that there are almost 3 million fetal and neonatal deaths every
Biosfer Teslab asiste a la International Manuel Rico NMR School From June 19th to 23rd, the XV edition of the
Spring Highlights: international actions, conferences, and courses Biosfer Teslab a leading innovator in metabolomic based health applications and NMR services,
Swiss Biotech Day 24 y 25 de abril de 2023 Last 24th and 25th April, the Swiss Biotech Day took
Metabolomics: Personalised precision medicine is here With omics technologies we can obtain a more objective and complete view of the
Premis TOYP organitzats per la JCI Reus i la JCI Catalunya La jove cambra de Catalunya compren una xarxa de
TOYP Awards organised by JCI Reus and JCI Catalonia The Young Chamber of Catalonia comprises a network of young people
Cambra Reus 2022 awards Once again, the Cambra Reus 2022 awards ceremony for innovation and digital transformation took place on
Biosfer Teslab at the International Conference on Genomic Medicine 2022 We only know what we know… We have to continue
Abstract Background and aims: Inflammation is a pathophysiological mechanism of atherosclerosis, and several mediators have been proposed as biomarkers. Acute-phase serum
Abstract Preeclampsia (PE) and fetal growth restriction (FGR) are both placenta-mediated disorders with unclear pathogenesis. Metabolomics of maternal and fetal
